Author: Greg Richter

Greg is a news manager who covers Medicine, Public Health, Biomedical Engineering, Science and Health Systems. He graduated from Rowan University, where he also worked in its Office of Media and Public Relations and also had a brief stint as its mascot for the opening of its medical school. Since then, he has lived in Philadelphia for eight years and worked in Penn Medicine’s Office of Communications, most recently as a senior medical communications officer. When not covering news at Drexel, he’s trying out a new recipe or trying to decide if he actually enjoys running. Follow him @DrexelGreg or view his blog posts here. Contact Greg at gdr33@drexel.edu or 215-895-2614.
Read More

The Pandemic Will End, but We’re Probably Stuck with the Coronavirus

Many scientists believe that SARS-CoV-2, the virus responsible for COVID-19, will become “endemic.” It will seasonally circulate in a similar fashion to the other common respiratory viruses, such as those that cause the common cold or flu. If this bears out, there will not be a true end to the pandemic (with accompanying ticker tape parade down Broad Street), but a gradual transition, to an illness that we will have to live with.

Read More

From Bed to Bedside: How One of the Nation’s Few Remaining Physician Re-entry Programs Moved Online to Support Physician Shortage

Re-entering medicine isn’t easy, as such candidates face credentialing, regulatory guidelines, financial hurdles, and other obstacles. Perhaps the biggest obstacle is finding and acceptance into one of the few re-entry programs operating in the United States, such as Drexel College of Medicine’s Physician Refresher/Re-Entry program.

Read More

Drexel and Tower Health Researchers Study Immune Responses Among COVID-19 Patients in Nationwide NIH Study

Researchers at Drexel University’s College of Medicine and Tower Health are among 10 leading medical institutions nationwide embarking on a study funded by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to uncover insights that may help answer these questions and others about the immune responses to COVID-19.